New hope for Tough-to-Treat blood cancers: experimental pill shows promise
Disease control
Ongoing
This early-stage study is testing an experimental oral drug called CFT7455 in about 224 adults with non-Hodgkin's lymphoma or multiple myeloma that has returned or stopped responding to standard treatments. The main goals are to check the drug's safety, find the best dose, and se…
Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC